Fujian Yuanli Active CarbonLtd Valuation
Is 300174 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Unter dem Marktwert
Deutlich unter dem Marktwert
Price-To-Earnings gegen Gleichaltrige
Price-To-Earnings gegen Industrie
PM vs. Fair Ratio
Analysten-Prognose
Share Price vs Fair Value
What is the Fair Price of 300174 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Unter dem Marktwert: 300174 (CN¥13.27) wird über unserer Schätzung des Fair Value (CN¥0.8) gehandelt.
Deutlich unter dem Marktwert: 300174 über unserer Schätzung des beizulegenden Zeitwerts gehandelt wird.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 300174?
Other financial metrics that can be useful for relative valuation.
| What is 300174's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | CN¥6.04b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2.6x |
| Enterprise Value/EBITDA | 14.6x |
| PEG Ratio | 0.9x |
Price to Earnings Ratio vs Peers
How does 300174's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 28.3x | ||
002125 Xiangtan Electrochemical ScientificLtd | 22x | 30.0% | CN¥6.2b |
300109 Boai NKY Medical Holdings | 12.5x | n/a | CN¥6.4b |
300848 Miracll ChemicalsLtd | 63.5x | 84.1% | CN¥6.3b |
605183 Quechen Silicon Chemical | 15.3x | n/a | CN¥5.7b |
300174 Fujian Yuanli Active CarbonLtd | 25.8x | 28.1% | CN¥6.0b |
Price-To-Earnings gegen Gleichaltrige: 300174 ist ein guter Wert, wenn man sein Price-To-Earnings Verhältnis (20.5x) mit dem Durchschnitt der anderen Unternehmen (22.8x) vergleicht.
Price to Earnings Ratio vs Industry
How does 300174's PE Ratio compare vs other companies in the CN Chemicals Industry?
Price-To-Earnings gegen Industrie: 300174 ist aufgrund seines Price-To-Earnings Verhältnisses (20.5x) im Vergleich zum CN Chemicals Branchendurchschnitt (26.9x) ein guter Wert.
Price to Earnings Ratio vs Fair Ratio
What is 300174's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 25.8x |
| Fair PE Ratio | 20.3x |
PM vs. Fair Ratio: 300174 ist teuer auf der Grundlage des Verhältnisses Price-To-Earnings (20.5x) im Vergleich zum geschätzten fairen Verhältnis Price-To-Earnings (18.5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analysten-Prognose: Unzureichende Daten für eine Preisprognose.